Christophe Van Dijck

Medicine & Life Sciences

1. Neisseria gonorrhoeae 100%
2. Gonorrhea 93%
3. Azithromycin 83%
4. Sexually Transmitted Diseases 73%
5. Mouthwashes 66%
6. Neisseria 63%
7. Chlamydia 41%
8. Streptococcus pneumoniae 36%
9. HIV 36%
10. Mycoplasma genitalium 35%
11. Macrolides 34%
12. Cephalosporins 33%
13. Greenland 32%
14. Treponema pallidum 30%
15. Ribosomal Proteins 30%
16. Sexual Partners 29%
17. Belgium 29%
18. Placebos 27%
19. Quinolones 26%
20. Controlled Clinical Trials 26%
21. Incidence 25%
22. Ceftriaxone 24%
23. Cross-Over Studies 22%
24. Population 21%
25. Mutation 19%
26. Genome 19%
27. Genotype 17%
28. Therapeutics 14%
29. Cefixime 13%
30. Local Anti-Infective Agents 13%
31. Mentha 13%
32. Syphilis 12%
33. Doxycycline 10%
34. Bacteria 10%
35. Acinetobacter 9%
36. Linear Models 9%
37. Klebsiella pneumoniae 8%
38. Ciprofloxacin 8%
39. Saliva 7%
40. Tongue 7%
41. Heterosexuality 7%
42. Pseudomonas aeruginosa 7%
43. rRNA Genes 7%
44. Meningococcal Vaccines 6%
45. Oropharynx 5%
46. Guidelines 5%
47. 23S Ribosomal RNA 5%
48. Escherichia coli 5%
49. Pressure 5%
50. Cephalosporin Resistance 5%